LitCovid-sample-Enju  

PMC:7199903 / 11211-11910 JSONTXT 20 Projects

Annnotations TAB TSV DIC JSON TextAE Lectin_function IAV-Glycan

Id Subject Object Predicate Lexical cue
T58449 0-9 NN denotes Shielding
T28529 10-12 IN denotes of
T5747 13-16 DT denotes the
T98568 17-25 NN denotes receptor
T89375 26-33 NN denotes binding
T54690 34-39 NNS denotes sites
T85870 40-42 IN denotes on
T26176 43-46 DT denotes the
T37663 47-57 NN denotes SARS-CoV-2
T63166 58-63 NN denotes spike
T63470 64-66 IN denotes by
T24684 67-75 JJ denotes proximal
T78149 76-89 NN denotes glycosylation
T54872 90-95 NNS denotes sites
T62513 96-97 -LRB- denotes (
T4900 97-101 NN denotes N165
T14840 101-102 -COMMA- denotes ,
T39942 103-107 NN denotes N234
T51156 107-108 -COMMA- denotes ,
T48381 109-113 NN denotes N343
T51553 113-114 -RRB- denotes )
T58350 115-118 MD denotes can
T58513 119-121 VB denotes be
T19457 122-130 VBN denotes observed
T15145 130-131 -COMMA- denotes ,
T59932 132-142 RB denotes especially
T12181 143-147 WRB denotes when
T47142 148-151 DT denotes the
T6856 152-160 NN denotes receptor
T18107 161-168 NN denotes binding
T3324 169-175 NN denotes domain
T48261 176-178 VBZ denotes is
T13056 179-181 IN denotes in
T67892 182-185 DT denotes the
T64170 186-192 JJ denotes “down”
T94966 193-205 NN denotes conformation
T92249 207-210 DT denotes The
T59586 211-220 NN denotes shielding
T5292 221-223 IN denotes of
T70689 224-232 NN denotes receptor
T8257 233-240 NN denotes binding
T27437 241-246 NNS denotes sites
T61614 247-249 IN denotes by
T82323 250-257 NNS denotes glycans
T86889 258-260 VBZ denotes is
T30307 261-262 DT denotes a
T12215 263-269 JJ denotes common
T51427 270-277 NN denotes feature
T49590 278-280 IN denotes of
T38802 281-286 JJ denotes viral
T61183 287-300 NNS denotes glycoproteins
T76907 300-301 -COMMA- denotes ,
T37332 302-304 IN denotes as
T98432 305-313 VBN denotes observed
T45593 314-316 IN denotes on
T71768 317-327 NN denotes SARS-CoV-1
T77776 328-329 NN denotes S
T77141 330-331 -LRB- denotes (
T35190 331-333 CD denotes 10
T97187 333-334 -COMMA- denotes ,
T78772 335-337 CD denotes 13
T10341 337-338 -RRB- denotes )
T94527 338-339 -COMMA- denotes ,
T22015 340-345 NN denotes HIV-1
T22100 346-349 NN denotes Env
T57063 350-351 -LRB- denotes (
T5763 351-353 CD denotes 27
T97555 353-354 -RRB- denotes )
T57498 354-355 -COMMA- denotes ,
T85313 356-365 NN denotes influenza
T97193 366-379 NN denotes hemagglutinin
T20094 380-381 -LRB- denotes (
T68894 381-383 CD denotes 28
T9711 383-384 -COMMA- denotes ,
T14487 385-387 CD denotes 29
T79925 387-388 -RRB- denotes )
T14459 388-389 -COMMA- denotes ,
T91683 390-393 CC denotes and
T25890 394-398 NN denotes LASV
T33313 399-402 NN denotes GPC
T68781 403-404 -LRB- denotes (
T25051 404-406 CD denotes 24
T35249 406-407 -RRB- denotes )
T9674 409-414 VBN denotes Given
T16190 415-418 DT denotes the
T24105 419-429 JJ denotes functional
T57734 430-441 NNS denotes constraints
T80185 442-444 IN denotes of
T49272 445-453 NN denotes receptor
T85530 454-461 NN denotes binding
T83026 462-467 NNS denotes sites
T78059 468-471 CC denotes and
T37003 472-475 DT denotes the
T67847 476-485 VBG denotes resulting
T72670 486-489 JJ denotes low
T95866 490-498 NN denotes mutation
T64589 499-504 NNS denotes rates
T69365 505-507 IN denotes of
T16503 508-513 DT denotes these
T58459 514-522 NNS denotes residues
T18586 522-523 -COMMA- denotes ,
T62335 524-529 EX denotes there
T33505 530-532 VBZ denotes is
T12318 533-539 JJ denotes likely
T99016 540-549 JJ denotes selective
T86957 550-558 NN denotes pressure
T75378 559-561 TO denotes to
T28105 562-565 VB denotes use
T72006 566-574 JJ denotes N-linked
T2972 575-582 NNS denotes glycans
T22260 583-585 TO denotes to
T34986 586-596 VB denotes camouflage
T24076 597-600 CD denotes one
T21165 601-603 IN denotes of
T9973 604-607 DT denotes the
T11278 608-612 RBS denotes most
T77436 613-622 VBN denotes conserved
T58170 623-626 CC denotes and
T50830 627-638 RB denotes potentially
T24871 639-649 JJ denotes vulnerable
T52029 650-655 NNS denotes areas
T36121 656-658 IN denotes of
T20657 659-664 PRP-DOLLAR- denotes their
T54396 665-675 JJ denotes respective
T26508 676-689 NNS denotes glycoproteins
T81527 690-691 -LRB- denotes (
T28240 691-693 CD denotes 30
T58247 693-694 -COMMA- denotes ,
T69248 695-697 CD denotes 31
T48597 697-698 -RRB- denotes )
R10980 T59586 T92249 arg1Of shielding,The
R11304 T3324 T18107 arg1Of domain,binding
R11523 T33505 T18586 arg1Of is,","
R12092 T33505 T9674 arg1Of is,Given
R12247 T63166 T26176 arg1Of spike,the
R15661 T3324 T13056 arg1Of domain,in
R1768 T51427 T86889 arg2Of feature,is
R17688 T97193 T91683 arg1Of hemagglutinin,and
R17739 T57734 T24105 arg1Of constraints,functional
R18196 T69248 T58247 arg2Of 31,","
R19144 T79925 T20094 arg3Of ),(
R20003 T26508 T54396 arg1Of glycoproteins,respective
R20672 T59586 T5292 arg1Of shielding,of
R2103 T62335 T33505 arg1Of there,is
R21038 T35190 T97187 arg1Of 10,","
R21640 T57498 T45593 arg2Of ",",on
R21703 T57734 T9674 arg2Of constraints,Given
R2190 T28240 T81527 arg2Of 30,(
R22894 T51427 T49590 arg1Of feature,of
R23552 T4900 T62513 arg2Of N165,(
R24140 T28105 T75378 arg1Of use,to
R24299 T58449 T19457 arg2Of Shielding,observed
R24822 T2972 T28105 arg2Of glycans,use
R24865 T97193 T85313 arg1Of hemagglutinin,influenza
R25182 T33313 T25890 arg1Of GPC,LASV
R25492 T52029 T77436 arg1Of areas,conserved
R26042 T24871 T58170 arg2Of vulnerable,and
R26387 T83026 T85530 arg1Of sites,binding
R27828 T5763 T57063 arg2Of 27,(
R2818 T58449 T85870 arg1Of Shielding,on
R28714 T54872 T78149 arg1Of sites,glycosylation
R30249 T86957 T75378 modOf pressure,to
R30457 T78059 T80185 arg2Of and,of
R30921 T59586 T86889 arg1Of shielding,is
R31355 T52029 T24871 arg1Of areas,vulnerable
R31496 T61183 T38802 arg1Of glycoproteins,viral
R31995 T58459 T16503 arg1Of residues,these
R32490 T58459 T69365 arg2Of residues,of
R33957 T77776 T71768 arg1Of S,SARS-CoV-1
R34052 T34986 T22260 arg1Of camouflage,to
R34199 T25051 T68781 arg2Of 24,(
R34699 T3324 T6856 arg1Of domain,receptor
R37211 T59586 T61614 arg1Of shielding,by
R38503 T57734 T16190 arg1Of constraints,the
R39703 T97193 T20094 arg1Of hemagglutinin,(
R42170 T19457 T15145 arg1Of observed,","
R43041 T52029 T36121 arg1Of areas,of
R43228 T22100 T94527 arg2Of Env,","
R43336 T48381 T51156 arg2Of N343,","
R43856 T4900 T14840 arg1Of N165,","
R45664 T64589 T67847 arg1Of rates,resulting
R47493 T77776 T94527 arg1Of S,","
R48030 T2972 T72006 arg1Of glycans,N-linked
R4814 T64589 T37003 arg1Of rates,the
R48732 T26508 T36121 arg2Of glycoproteins,of
R48795 T58449 T58513 arg1Of Shielding,be
R50235 T24871 T50830 arg1Of vulnerable,potentially
R51019 T19457 T58350 arg2Of observed,can
R5379 T86957 T99016 arg1Of pressure,selective
R55509 T91683 T14459 arg1Of and,","
R55549 T27437 T5292 arg2Of sites,of
R55601 T83026 T78059 arg1Of sites,and
R55910 T63166 T85870 arg2Of spike,on
R56023 T24076 T21165 arg1Of one,of
R5780 T28240 T58247 arg1Of 30,","
R58253 T94527 T57498 arg1Of ",",","
R5833 T63166 T37663 arg1Of spike,SARS-CoV-2
R58654 T33313 T91683 arg2Of GPC,and
R60516 T52029 T21165 arg2Of areas,of
R60900 T64589 T78059 arg2Of rates,and
R61177 T27437 T70689 arg1Of sites,receptor
R61306 T54690 T89375 arg1Of sites,binding
R61619 T78772 T97187 arg2Of 13,","
R63787 T98432 T37332 arg2Of observed,as
R63825 T54872 T62513 arg1Of sites,(
R64017 T3324 T48261 arg1Of domain,is
R65618 T54690 T5747 arg1Of sites,the
R66425 T4900 T51156 arg1Of N165,","
R6692 T61183 T49590 arg2Of glycoproteins,of
R67850 T52029 T81527 arg1Of areas,(
R68155 T34986 T28105 arg3Of camouflage,use
R68250 T54690 T28529 arg2Of sites,of
R69248 T57734 T80185 arg1Of constraints,of
R69704 T10341 T77141 arg3Of ),(
R69825 T59932 T12181 arg1Of especially,when
R69932 T77436 T58170 arg1Of conserved,and
R71623 T14487 T9711 arg2Of 29,","
R73043 T64589 T72670 arg1Of rates,low
R73463 T33313 T68781 arg1Of GPC,(
R74106 T19457 T59932 arg1Of observed,especially
R74659 T51427 T30307 arg1Of feature,a
R74703 T22100 T57063 arg1Of Env,(
R75194 T58449 T63470 arg1Of Shielding,by
R75586 T35249 T68781 arg3Of ),(
R76217 T58449 T28529 arg1Of Shielding,of
R76241 T94966 T13056 arg2Of conformation,in
R77160 T97187 T77141 arg2Of ",",(
R78260 T91683 T57498 arg2Of and,","
R7830 T54872 T63470 arg2Of sites,by
R78332 T54872 T24684 arg1Of sites,proximal
R78656 T9711 T20094 arg2Of ",",(
R78666 T3324 T47142 arg1Of domain,the
R79682 T22100 T22015 arg1Of Env,HIV-1
R81579 T94966 T64170 arg1Of conformation,“down”
R82433 T51427 T12215 arg1Of feature,common
R82933 T13056 T48261 arg2Of in,is
R83307 T99016 T12318 arg1Of selective,likely
R83613 T82323 T61614 arg2Of glycans,by
R84383 T39942 T14840 arg2Of N234,","
R84426 T26508 T20657 arg1Of glycoproteins,their
R84670 T77776 T77141 arg1Of S,(
R86137 T19457 T58513 arg2Of observed,be
R86311 T64589 T69365 arg1Of rates,of
R88232 T48261 T59932 arg2Of is,especially
R88363 T83026 T49272 arg1Of sites,receptor
R88573 T58449 T58350 arg1Of Shielding,can
R88583 T68894 T9711 arg1Of 28,","
R90241 T64589 T95866 arg1Of rates,mutation
R90460 T27437 T8257 arg1Of sites,binding
R91387 T51553 T62513 arg3Of ),(
R92771 T94966 T67892 arg1Of conformation,the
R92789 T24076 T34986 arg2Of one,camouflage
R93426 T52029 T9973 arg1Of areas,the
R94186 T86889 T37332 arg1Of is,as
R95409 T54690 T98568 arg1Of sites,receptor
R96681 T86889 T76907 arg1Of is,","
R96699 T97555 T57063 arg3Of ),(
R98228 T77436 T11278 arg1Of conserved,most
R98287 T98432 T45593 arg1Of observed,on
R98454 T86957 T33505 arg2Of pressure,is
R98924 T48597 T81527 arg3Of ),(